Smoking Cessation for Fathers of Sick Children
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18+
SponsorThe University of Hong Kong
About this trial
The project aims to develop and examine the feasibility, acceptability, and preliminary effectiveness of a proactive intervention model combined brief advice, nicotine replacement therapy sampling and mHealth-based individual counselling in increasing smoking abstinence for fathers of sick children.
Eligibility criteria
Qualifiers
Parents (mainly fathers) aged ≥18 years and smoke at least one cigarette (including alternative tobacco products) daily in the past seven days
Living with a child aged <18 years who attended the clinic or were admitted to the pediatric ward
Hong Kong residents able to read and communicate in Cantonese or Putonghua
Owned a smartphone and can use an instant messaging app (e.g., WhatsApp, Facebook) Inclusion criteria for children
Disqualifiers
Smokers having a history of psychiatric/psychological disease or currently on regular psychotropic medications
Smokers using smoking cessation medications or other smoking cessation services or projects Exclusion criteria for children
Children who already have serious health diseases (e.g.chronic disease, genetic disease)
Children who are participating in other clinical trials that may affect the results of this study
Trial design
Treatments tested in this trial
- Nicotine Replacement Therapy (NRT) Sampling
- mHealth-based motivational counselling
- Brief cessation advice and self-help material
Treatment groups
160 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov